torcetrapib has been researched along with colforsin in 2 studies
| Studies (torcetrapib) | Trials (torcetrapib) | Recent Studies (post-2010) (torcetrapib) | Studies (colforsin) | Trials (colforsin) | Recent Studies (post-2010) (colforsin) |
|---|---|---|---|---|---|
| 273 | 28 | 83 | 13,460 | 46 | 1,298 |
| Protein | Taxonomy | torcetrapib (IC50) | colforsin (IC50) |
|---|---|---|---|
| nuclear receptor subfamily 0 group B member 1 | Homo sapiens (human) | 1.729 | |
| 5-hydroxytryptamine receptor 1A | Homo sapiens (human) | 0.041 | |
| Adenylate cyclase type 1 | Homo sapiens (human) | 0.0955 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boccard, J; Imhof, RM; Jeanneret, F; Kratschmar, DV; Malagnino, V; Odermatt, A; Patt, M; Rudaz, S; Strajhar, P; Tonoli, D | 1 |
| Boccard, J; Jeanneret, F; Odermatt, A; Rudaz, S; Strajhar, P; Tonoli, D | 1 |
2 other study(ies) available for torcetrapib and colforsin
| Article | Year |
|---|---|
Steroid profiling in H295R cells to identify chemicals potentially disrupting the production of adrenal steroids.
Topics: Adrenal Glands; Cell Line, Tumor; Cinnamates; Citrates; Colforsin; Endocrine Disruptors; Endpoint Determination; Estradiol; Gene Expression Regulation; Guidelines as Topic; Humans; Quinolines; Reproducibility of Results; RNA, Messenger; Steroids; Testosterone; Toxicity Tests | 2017 |
Removal of batch effects using stratified subsampling of metabolomic data for in vitro endocrine disruptors screening.
Topics: Acrylates; Cell Line; Chromatography, High Pressure Liquid; Cinnamates; Citrates; Colforsin; Endocrine Disruptors; Gonadal Steroid Hormones; Humans; Linuron; Mass Spectrometry; Metabolomics; Quinolines | 2019 |